PMV PHARMACEUTICALS INC's ticker is PMVP and the CUSIP is 69353Y103. A total of 109 filers reported holding PMV PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.34 and the average weighting 0.9%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $19,425,701 | +97984.8% | 3,163,795 | 0.0% | 1.03% | +12.6% |
Q2 2023 | $19,805 | +31.2% | 3,163,795 | 0.0% | 0.92% | +23.9% |
Q1 2023 | $15,091 | -99.9% | 3,163,795 | 0.0% | 0.74% | -48.9% |
Q4 2022 | $27,525,016 | -26.9% | 3,163,795 | 0.0% | 1.45% | -31.5% |
Q3 2022 | $37,649,000 | -24.5% | 3,163,795 | -9.6% | 2.12% | -33.0% |
Q2 2022 | $49,856,000 | -31.6% | 3,498,636 | 0.0% | 3.16% | -15.7% |
Q1 2022 | $72,842,000 | +11.1% | 3,498,636 | +23.3% | 3.74% | +47.1% |
Q4 2021 | $65,563,000 | -3.0% | 2,838,236 | +25.1% | 2.55% | +7.9% |
Q3 2021 | $67,593,000 | -12.8% | 2,268,236 | 0.0% | 2.36% | -13.7% |
Q2 2021 | $77,483,000 | +3.9% | 2,268,236 | 0.0% | 2.73% | +8.1% |
Q1 2021 | $74,602,000 | -46.5% | 2,268,236 | 0.0% | 2.53% | -43.6% |
Q4 2020 | $139,519,000 | +73.3% | 2,268,236 | 0.0% | 4.48% | +61.2% |
Q3 2020 | $80,522,000 | – | 2,268,236 | – | 2.78% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
INTERWEST VENTURE MANAGEMENT CO | 3,234,911 | $74,726,000 | 44.17% |
Euclidean Capital LLC | 2,336,909 | $53,983,000 | 30.69% |
OUP Management Co., LLC | 989,232 | $22,851,000 | 10.30% |
Nextech Invest Ltd. | 1,385,807 | $32,012,000 | 8.43% |
Boxer Capital, LLC | 2,838,236 | $65,563,000 | 2.55% |
PERSONAL CFO SOLUTIONS, LLC | 550,342 | $12,713,000 | 2.38% |
Orbimed Advisors | 7,330,423 | $169,333,000 | 2.18% |
Asymmetry Capital Management, L.P. | 97,680 | $2,256,000 | 1.20% |
RTW INVESTMENTS, LP | 2,980,960 | $68,860,000 | 1.01% |
HighVista Strategies LLC | 39,777 | $919,000 | 0.73% |